Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:3296-3301
Published online before print June 13, 2005, doi: 10.1161/CIRCULATIONAHA.104.473165
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/24/3296    most recent
CIRCULATIONAHA.104.473165v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajamannan, N. M.
Right arrow Articles by Spelsberg, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajamannan, N. M.
Right arrow Articles by Spelsberg, T. C.
Related Collections
Right arrow Smooth muscle proliferation and differentiation
Right arrow Valvular heart disease
Right arrow CV surgery: valvular disease
Right arrow Other Research

(Circulation. 2005;111:3296-3301.)
© 2005 American Heart Association, Inc.


Valvular Heart Disease

Calcified Rheumatic Valve Neoangiogenesis Is Associated With Vascular Endothelial Growth Factor Expression and Osteoblast-Like Bone Formation

Nalini M. Rajamannan, MD; Thomas B. Nealis, BSc; Malayannan Subramaniam, PhD; Sanjay Pandya, MD; Stuart R. Stock, PhD; Constatine I. Ignatiev, PhD; Thomas J. Sebo, MD, PhD; Todd K. Rosengart, MD; William D. Edwards, MD; Patrick M. McCarthy, MD; Robert O. Bonow, MD; Thomas C. Spelsberg, PhD

From the Divisions of Cardiology and Cardiothoracic Surgery, Northwestern University, Feinberg School of Medicine, Chicago, Ill (N.M.R., T.B.N., S.P., P.M.M., R.O.B.); Departments of Molecular Biology and Biochemistry (M.S., T.C.S.) and Laboratory Medicine and Pathology (T.J.S., W.D.E.), Mayo Clinic, Rochester, Minn; Institute for Bioengineering and Nanoscience in Advanced Medicine, Northwestern University, Chicago, Ill (S.R.S., C.I.I.); Cardiology and Cardiothoracic Surgery, Northwestern Evanston Healthcare, Chicago, Ill (T.K.R.).

Correspondence to Nalini M. Rajamannan, MD, Northwestern University, Feinberg School of Medicine, 303 E Chicago, Tarry 12-717, Chicago, IL 60611. E-mail n-rajamannan{at}northwestern.edu

Received May 5, 2004; revision received February 9, 2005; accepted February 16, 2005.

Background— Rheumatic heart disease is the most common cause of valvular disease in developing countries. Despite the high prevalence of this disease, the cellular mechanisms are not well known. We hypothesized that rheumatic valve calcification is associated with an osteoblast bone formation and neoangiogenesis.

Methods and Results— To test this hypothesis, we examined human rheumatic valves replaced at surgery (n=23), normal human valves (n=20) removed at cardiac transplantation, and degenerative mitral valve leaflets removed during surgical valve repair (n=15). Microcomputed tomography was used to assess mineralization fronts to reconstruct the extents of mineralization. Immunohistochemistry was used to localize osteopontin protein, {alpha}-actin, osteocalcin, vascular endothelial growth factor, von Willebrand factor, and CD68 (human macrophage). Microcomputed tomography demonstrated complex calcification developing within the heavily calcified rheumatic valves, not in the degenerative mitral valves and control valves. Immunohistochemistry localized osteopontin and osteocalcin to areas of smooth muscle cells within microvessels and proliferating myofibroblasts. Vascular endothelial growth factor was present in areas of inflammation and colocalized with the CD68 stain primarily in the calcified rheumatic valves. Alizarin red, osteopontin, and osteocalcin protein expression was upregulated in the calcified rheumatic valves and was present at low levels in the degenerative mitral valves.

Conclusions— These findings support the concept that rheumatic valve calcification is not a random passive process but a regulated, inflammatory cellular process associated with the expression of osteoblast markers and neoangiogenesis.


Key Words: angiogenesis • calcification • cardiovascular diseases • rheumatic heart disease • valves




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. D. O'Brien
Pathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Rahimtoola
The Year in Valvular Heart Disease
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 427 - 439.
[Full Text] [PDF]